Skip to main content
Download PDF
Download ePub

Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study

Harm Reduction Journal volume 20, Article number: 90 (2023) Cite this article

Abstract

Background

Opioid use disorder (OUD) is overrepresented among people with criminal justice involvement; HIV is a common comorbidity in this population. This study aimed to examine how formerly incarcerated men living with HIV and OUD in South Africa experienced HIV and OUD services in correctional facilities and the community.

Methods

Three focus group discussions were conducted with 16 formerly incarcerated men living with HIV and OUD in Gauteng, South Africa. Discussions explored available healthcare services in correctional facilities and the community and procedural and practice differences in health care between the two types of settings. Data were analyzed thematically, using a comparative lens to explore the relationships between themes.

Results

Participants described an absence of medical services for OUD in correctional facilities and the harms caused by opioid withdrawal without medical support during incarceration. They reported that there were limited OUD services in the community and that what was available was not connected with public HIV clinics. Participants perceived correctional and community HIV care systems as readily accessible but suggested that a formal system did not exist to ensure care continuity post-release.

Conclusions

OUD was perceived to be medically unaddressed in correctional facilities and marginally attended to in the community. In contrast, HIV treatment was widely available within the two settings. The current model of OUD care in South Africa leaves many of the needs of re-entrants unmet. Integrating harm reduction into all primary care medical services may address some of these needs. Successful HIV care models provide examples of approaches that can be applied to developing and expanding OUD services in South Africa.

Background

Substance use disorders, particularly opioid use disorder (OUD), contribute significantly to the global burden of disease, including in low- and middle-income countries such as South Africa [1, 2]. The burden is disproportionately high among people who are involved with the criminal justice system. South Africa has a high incarceration rate, estimated at 236 people per 100,000 [3, 4]. The country has approximately 143,223 inmates, and between 55–95% of them face re-incarceration [3, 5]. The reported prevalence of substance use disorders in South African correctional facilities ranges from 15 to 42% [6,7,8]. Opioids were found to be among the principal substances used in one of the largest prisons in Durban [6, 8], although the specific types of substances used by South African inmates vary by correctional facility and region. Opioids, locally termed nyaope and woonga, are administered either through smoking or injecting, with around a quarter of users reporting injection [9, 10].

HIV, a common comorbidity of OUD, is highly prevalent among both the general and incarcerated populations in South Africa. The overall HIV prevalence in the country is estimated to be 13.9%, while the rate is estimated to be 20–23% among incarcerated men [4, 11, 12]. The high rates of OUD and HIV among the criminal justice-involved population results in a high proportion of inmates who are dually diagnosed [13,14,15]. When compared with OUD or HIV alone, a dual diagnosis is associated with increased morbidity and mortality and a higher risk for attrition along the HIV care continuum [16,17,18].

Antiretroviral therapy (ART) significantly reduces HIV-associated morbidity and mortality [19]. Access to ART in South African correctional settings is legally guaranteed to all incarcerated individuals living with HIV [20]. This access is provided in the forms of ART initiation for individuals not on ART, including same-day initiation for those diagnosed while incarcerated, and ART continuation during incarceration for those already on ART [20,21,22,23,24].

Similarly, adequate access to evidence-based treatment reduces OUD-related morbidity and mortality [25, 26]. South Africa’s OUD treatment system comprises a mix of private, public, and non-governmental organization (NGO)-provided services [8, 27]. Many of these services focus on short-term cessation and detoxification with or without the aid of medications [28, 29]. Harm reduction services, including needle and syringe programs and opioid substitution therapy, are mostly offered through NGOs in a limited number of locations [8, 30].

The nexus of HIV and opioid use among criminal justice-involved individuals provides an opportunity to support the healthcare needs of individuals living with both HIV and OUD. However, little has been described about the experiences of this population in correctional facilities or in the community. To assist with the development of patient-centered harm reduction services, we sought to understand how formerly incarcerated, dual-diagnosed individuals perceived and experienced HIV and OUD services in correctional facilities and the community [31,32,33,34]. This paper aims to provide detailed descriptions of how these services are currently accessed to offer insights into present access to and gaps in harm reduction services from the perspective of potential clients. It outlines opportunities and recommendations for creating and facilitating harm reduction practices in South Africa.

Methods

Design

As part of a broader study focused on understanding and characterizing substance use services among inmates and community re-entrants living with HIV in South Africa, we conducted focus group discussions (FGDs) with formerly incarcerated individuals living with HIV and current or past opioid use who resided in or close to Gauteng, South Africa. Participants were previously incarcerated in one of several correctional centers in Gauteng, South Africa.

Each correctional center has medical facilities where acute care and primary health care for chronic conditions and HIV are managed.

Study participants

Participants were recruited from a recently completed study conducted with people living with HIV who were transitioning back to the community from correctional facilities [ClinicalTrials.gov NCT]. Inclusion criteria were: (1) ≥ 18 years; (2) self-reported current or previous use of opioids; (3) living with HIV; and (4) able to provide informed consent. Study staff identified individuals who met the eligibility criteria; most participants were recruited through home visits while participants with access to cell phones were contacted telephonically. Individuals who were interested in participating were provided with additional study information and completed written informed consent prior to participation. This study was conducted according to the principles of the Declaration of Helsinki and received human subject research approval from the [Ethics Committees and Institutional Review Boards masked for blind review].

Focus group discussions

The FGDs followed a semi-structured guide that was informed by the Consolidated Framework for Implementation Research (CFIR). The CFIR consists of five a priori domains: inner setting, outer setting, intervention characteristics, process, and characteristics of individuals [35]. The FGD guide was designed to address the inner setting, which is primarily concerned with the structural characteristics, culture, and climate for implementation, and the characteristics of individuals involved in the implementation process, which include a person’s knowledge, abilities, relationships, and sense of self [35].

The discussions were ultimately structured around five topics: (1) availability of healthcare services in correctional facilities and the community; (2) use and experience of healthcare services, systems, and practices in correctional facilities; (3) use and experience of healthcare services, systems, and practices in the community; (4) procedural and practice differences in healthcare between correctional facilities and the community; and (5) community, correctional staff, and service provider attitudes. One to two hours were allocated to each topic, with 15-min breaks in between. FGDs occurred in several languages (English, isiZulu, Setswana, and Sepedi) and were guided by a trained facilitator fluent in these languages. All participants were encouraged to take part in the discussions. The FGDs were both audio-recorded and documented by one or two note takers present at each discussion.

Analysis

Audio-recordings of FGDs were transcribed, de-identified, and translated verbatim into English (as necessary). To ensure transcription quality, transcripts were compared to the original audio-recordings prior to data analysis [36]. Final transcripts were analyzed using thematic analysis adapted from Braun and Clarke’s six-step thematic analysis [37, 38] and included both iterative reading and group discussions. Key themes were identified then refined to ensure that each had enough meaningful and supportive data and was distinct from each other. Participants’ responses in these themes were summarized to present the findings, and illustrative quotes were selected to exemplify both dominant and atypical patterns of data [39]. Finally, an exploration of the relationship between themes was performed through a comparative lens. We limited this analysis to experiences or observations regarding opioid use and HIV treatment services in correctional facilities and in the community.

Results

A total of three FGDs were conducted from May 2021 to June 2021 among 16 formerly incarcerated men living with HIV and OUD; two with groups of 5 participants and one with 6 participants. Each FGD was conducted in two sessions over two days. Each session lasted between 120–180 min, totaling four to five hours per FGD. All participants were men; we did not succeed in recruiting female participants for this particular study on treatment services experiences. Their median age was 33 years (interquartile range [IQR]: 29, 36), the median duration of ART prior to correctional facility release was 6 months (IQR: 4, 19), and the median duration of incarceration was 7 months (IQR: 5, 20).

We organized our findings under four categories: Opioid use services in correctional facilities, HIV services in correctional facilities, opioid use services in the community, and HIV services in the community. The services were summarized for each theme and compared across themes (Table 1).

Table 1 Summary of themes and relationship between themes
Full size table

Correctional facilities

Opioid use services

Participants described an absence of services, medical or otherwise, for opioid use in correctional facilities. They stated that they did not receive assistance with medical management of opioid withdrawal, cessation, or harm reduction from the correctional staff (wardens or medical personnel). They also reported experiencing a lack of palliating measures or support with withdrawal symptoms. One participant described the procedure for managing withdrawal as follows:

[Prison name] is a small prison.... Everybody comes in with withdrawal symptoms and they [wardens] don’t give you medication or anything. You vomit until you become well and recover. (KK, FG2)

Participants perceived that the wardens generally considered opioid use a disciplinary issue rather than a health issue. Wardens did not provide services or respond to symptoms of opioid dependence or withdrawal and equated an absence of acute withdrawal symptoms with “recovery.” Inmates felt that they were expected to “rehabilitate” themselves without medical or other assistance. In the words of one participant:

You see in prison madam, there is nothing for drugs or rehabilitation. There, they [the correctional officials] have told themselves that you are going to rehab yourself, you see, even though the notion that you will rehab yourself doesn’t work. (LI, FG2)

Overall, participants reported no experiences of health services for OUD management or for alleviating withdrawal symptoms during incarceration.

HIV services

All participants described accessing services for HIV in correctional facilities. There was a consensus among the participants that correctional facility HIV care was governed by a regimented system that provided structured support. Upon admission, inmates underwent health screening for infectious diseases such as HIV and tuberculosis but not for OUD. Many participants said that they were unaware of their HIV status prior to entering the facility and recalled receiving assistance from correctional health services with HIV diagnosis, emotional well-being, and ART initiation. As one participant shared:

In prison they helped us to know our status madam, because we were not aware that we are sick… We were all over the place and we were smoking [nyaope]...We were checked, and we ended up knowing that we must take medication. (LI, FG2)

For some participants, the structured nature of HIV services in correctional facilities made care readily accessible:

Every time I had to fetch medication, in the morning they would come to my cell and call out my name. I would go out with them and go to the front. When I get there, my things are already ready; I would take my things. They would check me the way they check me, and I would go back. (PO, FG2)

A number of participants also valued how HIV appointments and ART collection were organized in correctional facilities. Several participants said that correctional staff enabled them to receive consistent and timely treatment. As one participant explained:

In prison they are able to fetch you even when you are sleeping on your scaffol [bunk]. They were also able to call me to say, my man, it’s your treatment collection, come and collect it, you see… they would also ring a bell to symbolize that it’s treatment collection. (KG, FG2)

Despite this structure, several participants reported that access to HIV care could depend on the discretion of individual wardens. Wardens could refuse to escort inmates to the clinic or seemed to selectively favor certain individuals. As a result, HIV services were sometimes delayed or not received. As one participant observed:

It [access to treatment] depends on the shifts of the chiefs...There are people called escorts here in prison, sister... They can really be problematic. Let’s say it’s another chief’s shift who is cruel or lazy… He will only take those people close to him... If he is lazy, he can just leave you... He will not give you an escort and without an escort no one can leave and go to a certain place. (KA, FG1)

Participants’ reflections about the inconsistency in being escorted to care stood in contrast to overwhelmingly positive experiences of interacting with correctional healthcare staff. When describing encounters with healthcare staff, they said that providers were patient and worked professionally:

Most of the time the ones in prison are concerned and they really work. They give their time to the inmates, you understand. (NI, FG2)

In communities

Opioid use services

Participants reported being aware of a variety of OUD services in their communities ranging from brief detoxification to non-medication-based rehabilitation and group therapy to medications for opioid use disorder (MOUD). Notably, none of these OUD services were integrated with HIV services, and no public clinics offered OUD services. Limited harm reduction programs, including those that offered needle exchange services, were primarily provided by a small number of NGOs. One participant described such an NGO:

Oh [Organization A], the ones driving Ivecos [vans]. They also take out medication, they provide testing services, they give syringes, swabs, water, then they give you pills. They also open up a file for you. They come on a monthly basis. (KK, FG2)

In terms of medication, a few participants recalled receiving methadone for OUD treatment in their communities from NGOs or other community-based organizations. They described the medication as effective for reducing short-term withdrawal symptoms. On the other hand, several participants emphasized that willpower was paramount to “recovery”:

It [methadone] works. It works and mostly it’s all about willpower of an individual. If you are too serious about quitting drugs. (KB, FG1)

Many participants described cessation of substance use as the primary responsibility of the motivated individual. There was a general perception that substance use programs and organizations provided behavioral tools that could augment individual willpower. Aligned with this perception was a common view that many programs were oriented toward assisting with overcoming acute withdrawal symptoms and that individual willpower was the ingredient for long-term recovery goals:

It [program] will work if like [program staff] saying, the right things are in place and the sufferer or addict is willing to make use of all the avenues available, you see. Then okay, all comes up for him (D, FG1)

Consistent with their belief in the importance of willpower, most participants reported that they had engaged in detoxification and cessation-based strategies, with minimal linkages to long-term OUD services. They also knew of a particularly extreme “treatment” for opioid use offered by an apostolic church, although none had personal experience of the service. As one participant explained:

In my township, there is a place called a Church of [Anonymized]. If you were smoking [nyaope], when you arrive, … there is a pillar, they tie you to a chain. I don’t know for how many days you stay there. (SP, FG3)

Although extreme, this was one example of a substance use-oriented program being provided in a participant’s community. The general principle of abstinence and overcoming acute withdrawal is consistent with most participants’ views that the route to sustained opioid use cessation is a matter of suffering and individual willpower. For instance, many participants characterized substance use recovery as an individual experience where one “quit[s] on [one’s] own” (P, FG2). They perceived the recovery process, including its challenges, as occurring “all in the mind” (S, FG2) of the individual. Instead of a medical problem, substance use was often viewed as a moral or behavioral failing resulting from limited self-control.

HIV services

All participants reported that HIV services were readily available in communities. However, accessing these services sometimes required substantial individual initiative. Participants said that they found themselves without structured support to keep up with the demands of treatment for a chronic condition. As one participant explained,

Out here [in the community], they will never ring a bell for you and say, ‘Come and collect your medication.’ (KG, FG2)

In fact, for some participants, the lack of regimented system following release from correctional facilities resulted in nonadherence to ART:

While I was in prison I adhered to treatment. But when I got out, the time to drink my medication, I would miss it, you see. I have since realized that the time of taking medication was a problem. (SK, FG3)

Experiences of interacting with healthcare providers in the communities were mixed. One participant spoke of the variable nature of healthcare and how patient experiences were influenced by the attitudes of providers:

I can say that at clinics the staff are not the same, you can go this week and find that you meet [the] right nurses who have patience and next time you find another one who will say take the tablets. You find another one will say you need to draw blood first before you get medication… Do you understand so you can no longer know what’s the right approach, so I can say some are good and some are not. (SO, FG2)

Participants who recounted positive experiences described HIV care nurses to be empathetic and motivated to help them with their transition back into the community, and several attributed their ability to continue post-release HIV care to this support. As one participant explained:

Outside it’s different. The health care service outside, people feel that if you are somebody who is infected [with HIV] and you come to the clinic for the first time, they really go all the way to help you. (DE, FG1)

Discussion

In this study, formerly incarcerated men living with OUD and HIV described experiencing a lack of health services for OUD in correctional facilities and limited services for OUD in their communities. Furthermore, what was available was not co-located with HIV services. Participants reported enduring acute and ongoing opioid withdrawal symptoms without medical alleviation during incarceration. Outside correctional facilities, NGOs provided most OUD services. Many participants viewed cessation from opioid use through a lens of individual agency and willpower, reflecting prevailing views toward substance use cessation in South Africa [28].

We found discrepancies between the accessibility of OUD care compared to HIV care in both correctional facilities and the communities. Such discrepancies may be partially attributable to differences in South Africa’s policies regarding drug use and HIV. South Africa’s adoption of the universal-test-and-treat policy in 2016 and the same-day ART initiation policy in 2017 placed the country in accordance with recommendations from the World Health Organizations and has expanded HIV treatment [24, 40]. In contrast, the National Drug Master Plans (1999–2024), South Africa’s guiding substance use policy documents, have traditionally placed increasing emphasis on punishment or reintegration [41]. The most recent National Drug Master Plan (2019–2024) released in 2020 does call for a shift toward harm reduction, including in correctional facilities, but actual implementation is still in early stages [10]. This overarching conservatism is consistent with South Africa’s historically prohibitionist attitude toward substance use, as demonstrated by its signatory in the Single Convention on Narcotic Drugs and the Prevention and Treatment of Drug Dependency Act [41]. Structurally, HIV and OUD services are also managed by different administrative entities. Unlike HIV care, which is delivered to patients as a part of the primary healthcare system through the Department of Health, substance use services are overseen by the Department of Social Development, with inputs from the Department of Health for detoxification and co-morbidity management [42]. While the Department of Health has advocated for a more public health-oriented approach to substance use, the Department of Social Development has shown a consistent preference for abstinence-based approaches [41].

These findings underscore an opportunity to re-orient OUD services among people involved in the criminal justice system in South Africa by establishing a medical response within a harm reduction model. This approach is a practical way to address the experiences reported in this study and prior studies’ descriptions of punishment, detoxification, and substance supply interdiction [28, 43, 44]. Evidence indicates that implementing MOUD using a harm reduction approach can improve treatment outcomes [45,46,47,48]. For formerly incarcerated individuals living with both OUD and HIV, the co-localization of OUD services with HIV care has the potential to further improve the accessibility and uptake of these services [49, 50]. Given that HIV care in South Africa is delivered through the primary health care system and the Department of Health while OUD care is largely overseen by the Department of Social Development, the co-localization of these services in clinical settings may provide an opportunity to medicalize OUD and incorporate associated services into the general healthcare system [42]. Furthermore, prior studies that examined outcomes of integrated HIV and OUD services indicate that clients are more likely to access services when they are co-located in a single setting [51].

Even though OUD poses a significant challenge to South Africa’s healthcare system, notable parallels exist between the country’s current limited clinical capacity to address OUD and its capacity to address the HIV epidemic 20 years ago. At the beginning of the HIV epidemic, ART was not provided in correctional facilities or communities, HIV was highly stigmatized, and health care providers often had limited knowledge of HIV treatment [52,53,54,55,56]. Given that people living with HIV and OUD confront many similar challenges, including stigma, lack of social support, and financial distress, successful HIV care models provide examples of applicable early-stage approaches toward opioid use services in South Africa [57,58,59]. In particular, the structured nature of correctional HIV care, which supports ART adherence, can serve as a model for delivering OUD services, particularly MOUD [60, 61].

While HIV services in correctional facilities and in the community may serve as models for developing a medical response to opioid use, they have limitations. Participants described a mix of highly supportive interactions and some hindering interactions in receiving care in both correctional facilities and the community. Although not explored in this study, it is possible that substance use increased the animosity or stigmatization in or outside of correctional facilities, making HIV services less accessible.

Our study has the strength of including participants living with HIV who were recently incarcerated and had documented opioid use. In addition, the study was achieved by a team that had established an excellent rapport with participants, facilitating recruitment and open discussion. The study also has several limitations. Participants constituted a convenience sample of re-entrants living with HIV who were using or had previously used opioids and may not be demographically representative of population overall [62]. Furthermore, this study was conducted with a relatively small sample of male participants in a single, high-burden urbanized region in South Africa. Its findings may not be generalizable to other urban or remote and rural areas with fewer and less diverse service options [63], and they do not capture the experiences of female re-entrants with HIV/OUD comorbidity. Research has shown that female criminal justice-involved individuals often have greater health needs than their male counterparts and experience greater levels of stigma [64, 65].

Opioid use is a challenge for the criminal justice system, communities, and goals of HIV epidemic control in South Africa. The intersection of OUD, HIV, and the criminal justice system creates an opportunity to provide acceptable and accessible harm reduction-based services to incarcerated individuals and those re-entering communities. To succeed, such an initiative needs to be integrated into existing HIV and primary healthcare services in both correctional facilities and community settings through appropriately trained, equipped, and supported public, private, and third-party providers with a clear and measured plan of implementation.

Conclusions

Our findings indicate that there is an opportunity to create harm reduction-based services for OUD in correctional facilities and communities in South Africa through integrated HIV/OUD healthcare. The success of initiating such a programmatic intervention hinges upon shifting common opioid use treatment perceptions away from abstinence and cure toward the provision of medical services for a chronic condition.

Availability of data and materials

The datasets used and/or analyzed in the current study are available from the corresponding author on reasonable request. The qualitative datasets are not publicly available in order to protect the participants’ privacy and confidentiality, particularly given the small sample size and the study’s geographic specificity. Study participants with stigmatized traits disclosed rich, detailed, and sensitive information that may unintentionally reveal their identities.

Abbreviations

CFIR:

Consolidated framework for implementation research

HIV:

Human immunodeficiency virus

OUD:

Opioid use disorder

ART:

Antiretroviral therapy

NGO:

Non-Governmental Organization

MOUD:

Medications for opioid use disorder

References

  1. Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987–1012.

    Article  Google Scholar 

  2. Peltzer K, Phaswana-Mafuya N. Drug use among youth and adults in a population-based survey in South Africa. S Afr J Psychiatry. 2018;24:1139.

    Google Scholar 

  3. Department of Correctional Services RoSA. Department of Correctional Services Vote No. 22: Annual Report 2021/22 Financial Year. Pretoria, South Africa. 2022.

  4. Africa SS. Mid-year population estimates: 2022. Pretoria, South Africa. 2022.

  5. Murhula PBB, Singh SB, Nunlall R. A critical analysis on offenders rehabilitation approach in South Africa: a review of the literature. Afr Criminol Justice Stud. 2019;12:21.

    Google Scholar 

  6. Naidoo S, Mkize DL. Prevalence of mental disorders in a prison population in Durban, South Africa. Afr J Psychiatry (Johannesbg). 2012;15(1):30–5.

    CAS  PubMed  Google Scholar 

  7. Modupi MB, Mosotho NL, le Roux HE. The prevalence of mental disorders among offenders admitted at health facilities in Bizzah Makhate Correctional Service Centre, Kroonstand, South Africa. Psychiatr Psychol Law. 2020;27(6):963–72.

    Article  PubMed Central  Google Scholar 

  8. Dada S, Burnhams NH, Erasmus J, Lucas W, Parry C, Bhana A, et al. January–June 2020 (Phase 48): monitoring alcohol, tobacco and other drug abuse treatment admissions in South Africa. South Africa. 2021.

  9. Harker N, Lucas WC, Laubscher R, Dada S, Myers B, Parry CDH. Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017). Int J Drug Policy. 2020;83:102839.

    Article  PubMed  Google Scholar 

  10. Department of Social Developement RoSA. National Drug Master Plan 4th Edition, 2019 to 2024: South Africa Free of Substance Abuse. Gauteng. 2020.

  11. Telisinghe L, Fielding KL, Malden JL, Hanifa Y, Churchyard GJ, Grant AD, et al. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS ONE. 2014;9(1):e87262.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bank TW. Prevalence of HIV, total (% of population ages 15–49) UNAIDS estimates: The World Bank 2021. https://data.worldbank.org/indicator/SH.DYN.AIDS.ZS.

  13. Di Paola A, Altice FL, Powell ML, Trestman RL, Springer SA. A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community. Health Justice. 2014;2(11):11.

    Article  PubMed  Google Scholar 

  14. Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, et al. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug Alcohol Depend. 2015;151:68–75.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zahari MM, Hwan Bae W, Zainal NZ, Habil H, Kamarulzaman A, Altice FL. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse. 2010;36(1):31–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Azar P, Wood E, Nguyen P, Luma M, Montaner J, Kerr T, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis. 2015;15:193.

    Article  PubMed Central  Google Scholar 

  17. Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17(4):423–41.

    Article  PubMed  Google Scholar 

  18. Critchley L, Carrico A, Gukasyan N, Jacobs P, Mandler RN, Rodriguez AE, et al. Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol. Addict Sci Clin Pract. 2020;15(1):19.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sterne JAC, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. The Lancet. 2005;366(9483):378–84.

    Article  CAS  Google Scholar 

  20. Keehn EN, Nevin A. Health, human rights, and the transformation of punishment: South African litigation to address HIV and tuberculosis in prisons. Health Hum Rights. 2018;20(1):213–24.

    PubMed  PubMed Central  Google Scholar 

  21. Myburgh H, Reynolds L, Hoddinott G, van Aswegen D, Grobbelaar N, Gunst C, et al. Implementing ‘universal’ access to antiretroviral treatment in South Africa: a scoping review on research priorities. Health Policy Plan. 2021;36(6):923–38.

    PubMed Central  Google Scholar 

  22. UNAIDS. South Africa takes bold step to provide HIV treatment for all: UNAIDS; 2016 https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2016/may/20160513_UTT.

  23. Hirasen K, Fox MP, Hendrickson CJ, Sineke T, Onoya D. HIV treatment outcomes among patients initiated on antiretroviral therapy pre and post-universal test and treat guidelines in South Africa. Ther Clin Risk Manag. 2020;16:169–80.

    Article  PubMed  Google Scholar 

  24. Onoya D, Mokhele I, Sineke T, Mngoma B, Moolla A, Vujovic M, et al. Health provider perspectives on the implementation of the same-day-ART initiation policy in the Gauteng province of South Africa. Health Res Policy Syst. 2021;19(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.

    Article  Google Scholar 

  26. Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments. Harv Rev Psychiatry. 2020;28(5):316–27.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ellis G, Stein DJ, Thomas K, Meintjes EM. Substance use and abuse in South Africa: brain behaviour and other perspectives. Claremont: UCT Press; 2013.

    Google Scholar 

  28. Buxton J, Chinery-Hesse M, Tinasti K, Scheibe A, Shelly S, Versfeld A. Drug policies and development: conflict and coexistence: Brill | Nijhoff; 2020. pp. 274–304.

  29. Shelly S, Sigsworth R. Rethinking prohibition: towards an effective response to drugs in South Africa. 2020.

  30. Scheibe A, Marks M, Shelly S, Gerardy T, Domingo A, Hugo J. Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa. S Afr Med J. 2018;108:800.

    Article  CAS  PubMed  Google Scholar 

  31. Simon TA, Khouri MS, Kou TD, Gomez-Caminero A. Realizing the potential of the patient perspective. Patient Prefer Adherence. 2020;14:2001–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ross LE, Vigod S, Wishart J, Waese M, Spence JD, Oliver J, et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract. 2015;16:135.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Chau LW, Erickson M, Vigo D, Lou H, Pakhomova T, Winston ML, et al. The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders. Int J Drug Policy. 2021;97:103208.

    Article  PubMed  Google Scholar 

  34. Andraka-Christou B, Randall-Kosich O, Totaram R. Designing an “ideal” substance use disorder treatment center: perspectives of people who have utilized medications for opioid use disorder. Qual Health Res. 2021;31(3):512–22.

    Article  PubMed  Google Scholar 

  35. Keith RE, Crosson JC, O’Malley AS, Cromp D, Taylor EF. Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation. Implement Sci. 2017;12(1):15.

    Article  PubMed  Google Scholar 

  36. Tessier S. From field notes, to transcripts, to tape recordings: evolution or combination? Int J Qual Methods. 2012;11(4):446–60.

    Article  Google Scholar 

  37. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.

    Article  Google Scholar 

  38. Byrne D. A worked example of Braun and Clarke’s approach to reflexive thematic analysis. Qual Quant. 2022;56(3):1391–412.

    Article  Google Scholar 

  39. Lingard L. Beyond the default colon: effective use of quotes in qualitative research. Perspect Med Educ. 2019;8(6):360–4.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Probert WJM, Sauter R, Pickles M, Cori A, Bell-Mandla NF, Bwalya J, et al. Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study. Lancet HIV. 2022;9(11):e771–80.

    Article  CAS  PubMed  Google Scholar 

  41. Scheibe A, Shelly S, Versfeld A. Prohibitionist drug policy in South Africa—reasons and effects international development policy. 2020;12.

  42. Goldstone D, Bantjes J, Dannatt L. Mental health care providers’ suggestions for suicide prevention among people with substance use disorders in South Africa: a qualitative study. Subst Abuse Treat Prev Policy. 2018;13(1):47.

    Article  PubMed  Google Scholar 

  43. Geyer S, Lombard A. A content analysis of the South African national drug master plan: lessons for aligning policy with social development. Soc Work/Maatskaplike Werk. 2014;50:328–49.

    Article  Google Scholar 

  44. Africa UROfS. A stocktaking exercise of relevant national laws, policies and practices in South Africa, aiming to identify legal, policy, and practical gaps and obstacles for using alternatives to imprisonment with a specific focus on women arrested or detained for drug offenses. Pretoria. 2021.

  45. Marks M, Scheibe A, Shelly S. High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion. Harm Reduct J. 2020;17(1):25.

    Article  PubMed Central  Google Scholar 

  46. Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. A harm reduction approach to treating opioid use disorder in an independent primary care practice: a qualitative study. J Gen Intern Med. 2021;36(7):1898–905.

    Article  PubMed Central  Google Scholar 

  47. Fox AD, Chamberlain A, Frost T, Cunningham CO. Harm reduction agencies as a potential site for buprenorphine treatment. Subst Abuse. 2015;36(2):155–60.

    Article  Google Scholar 

  48. Scheibe A, Shelly S, Gerardy T, von Homeyer Z, Schneider A, Padayachee K, et al. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addict Sci Clin Pract. 2020;15(1):13.

    Article  PubMed  Google Scholar 

  49. Tofighi B, Sindhu SS, Chemi C, Lewis CF, Dickson VV, Lee JD. Perspectives on the HIV continuum of care among adult opioid users in New York City: a qualitative study. Harm Reduct J. 2019;16(1):58.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Taylor LE. Colocalization in hepatitis C virus infection care: the role of opioid agonist therapy clinics. Clin Liver Dis. 2020;16(1):12–5.

    Article  Google Scholar 

  51. Duffy M, Ghosh A, Geltman A, Mahaniah GK, Higgins-Biddle M, Clark M. Coordinating systems of care for HIV and opioid use disorder: a systematic review of enablers and barriers to integrated service access, and systems and tools required for implementation. Med Care Res Rev. 2022;79(5):618–39.

    Article  PubMed  Google Scholar 

  52. Zwi A, Bachmayer D. HIV and AIDS in South Africa: what is an appropriate public health response? Health Policy Plan. 1990;5(4):316–26.

    Article  Google Scholar 

  53. Benatar SR. Health care reform and the crisis of HIV and AIDS in South Africa. N Engl J Med. 2004;351(1):81–92.

    Article  CAS  Google Scholar 

  54. Okoror TA, Airhihenbuwa CO, Zungu M, Makofani D, Brown DC, Iwelunmor J. “My mother told me I must not cook anymore”—food, culture, and the context of HIV− and AIDS-related stigma in three communities in South Africa. Int Q Community Health Educ. 2008;28(3):201–13.

    Article  CAS  Google Scholar 

  55. Uys LR. Aspects of the care of people with HIV/AIDS in South Africa. Public Health Nurs. 2003;20(4):271–80.

    Article  Google Scholar 

  56. Ford N, Calmy A, Mills EJ. The first decade of antiretroviral therapy in Africa. Glob Health. 2011;7:33.

    Article  Google Scholar 

  57. Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013;21(4):S73–6.

    Article  PubMed  Google Scholar 

  58. Davies G, Elison S, Ward J, Laudet A. The role of lifestyle in perpetuating substance use disorder: the Lifestyle Balance Model. Subst Abuse Treat Prev Policy. 2015;10(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Dejman M, Ardakani HM, Malekafzali B, Moradi G, Gouya MM, Shushtari ZJ, et al. Psychological, social, and familial problems of people living with HIV/AIDS in Iran: a qualitative study. Int J Prev Med. 2015;6:126.

    Article  PubMed Central  Google Scholar 

  60. Rabinovich R, Owczarzak J, Mabuto T, Ntombela N, Woznica D, Hoffmann CJ. Social support needs of HIV-positive individuals reentering community settings from correctional facilities in Johannesburg, South Africa. AIDS Care. 2021:1–8.

  61. Stevenson K, Podewils L, Zishiri V, Castro K, Charalambous S. HIV prevalence and the cascade of care in five South African correctional facilities. PLoS ONE. 2020;15:e0235178.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Jager J, Putnick DL, Bornstein MH II. More than just convenient: the scientific merits of homogeous convenience samples. Monogr Soc Res Child Dev. 2017;82(2):13–30.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ndlovu DT, Hoffmann CJ. Including the criminal justice-involved at the HIV policy, research and service delivery table. J Int AIDS Soc. 2018;21(6):e25145.

    Article  PubMed  PubMed Central  Google Scholar 

  64. van Olphen J, Eliason MJ, Freudenberg N, Barnes M. Nowhere to go: how stigma limits the options of female drug users after release from jail. Subst Abuse Treat Prev Policy. 2009;4:10.

    Article  PubMed Central  Google Scholar 

  65. Van Hout MC, Mhlanga-Gunda R. Contemporary women prisoners health experiences, unique prison health care needs and health care outcomes in sub Saharan Africa: a scoping review of extant literature. BMC Int Health Hum Rights. 2018;18(1):31.

    Article  PubMed Central  Google Scholar 

Download references

Acknowledgements

We wish to thank all the study participants for their engagement and trust in the research process. We also wish to thank the many research staff and correctional service members who helped with the successful completion of this study.

Funding

This research was funded through a grant from the US National Institutes of Health Fogarty International Center: Grant No.: R21TW011689. The funder was not involved in the design, interpretation, or writing of this manuscript.

Author information

Author notes

  1. Yangxi An and Christopher J. Hoffmann contributed equally to this work.

Authors and Affiliations

  1. Krieger School for the Arts and Sciences, Johns Hopkins University, Baltimore, USA

    Yangxi An

  2. School of Medicine, Johns Hopkins University, 1550 Orleans St, CRBII 1M11, Baltimore, MD, 21207, USA

    Christopher J. Hoffmann & Laura Steiner

  3. Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA

    Christopher J. Hoffmann & Jill Owczarzak

  4. Community Oriented Substance Use Programme, Tshwane, South Africa

    Urvisha Bhoora, Sukholuhle Tshuma & Jannie Hugo

  5. Community Oriented Primary Care Research Unit, University of Pretoria, Tshwane, South Africa

    Urvisha Bhoora, Jannie Hugo & Tessa S. Marcus

  6. Aurum Institute, Johannesburg, South Africa

    Christopher J. Hoffmann, Pretty Ndini, Derrick Moyo & Tonderai Mabuto

  7. Department of Family Medicine, University of Pretoria, Tshwane, South Africa

    Urvisha Bhoora, Sukholuhle Tshuma, Jannie Hugo & Tessa S. Marcus

Authors
  1. Yangxi An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher J. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Urvisha Bhoora
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pretty Ndini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Derrick Moyo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laura Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sukholuhle Tshuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tonderai Mabuto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jannie Hugo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jill Owczarzak
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tessa S. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CJH: Obtained funding; CJH, TSM, JO: Conceived of and designed the study; CJH, TSM, JO, UB, PN, DTN: developed study tools including focus group discussion guide; PN, DTN: collected data; YA, CJH, UB, PN, DTN, LS, ST, TSM, JH, JO, TM: conducted analysis; YA: wrote a first draft; YA, CJH, UB, PN, DTN, LS, ST, TSM, JH, JO, TM: contributed to manuscript development. All authors reviewed and agreed with the submitted version.

Corresponding author

Correspondence to Christopher J. Hoffmann.

Ethics declarations

Ethics approval and consent to participate

The study was completed in compliance with all principles of the Declaration of Helsinki. It was approved by the South African Department of Correctional Services, the Witwatersrand Human Research Ethics Committee, the University of Pretoria Research Ethics Committee, and the Johns Hopkins University Medicine Institutional Review Board. Informed consent was obtained in written format from all study participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, Y., Hoffmann, C.J., Bhoora, U. et al. Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study. Harm Reduct J 20, 90 (2023). https://doi.org/10.1186/s12954-023-00834-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12954-023-00834-6

Keywords

Harm Reduction Journal

ISSN: 1477-7517